Complain about a product or service

Merck Acquitted In New Jersey Vioxx Case

November 3, 2005

Related Stories • Pfizer Pays Record $2.3 Billion Settlement Over Illegal Marketing Charges • Court Snuffs Vioxx Suit • Pfizer Pays $894 Million to Settle NSAID Claims • Researchers Claim Vioxx Safety Study Was Actually Marketing Plan • First Vioxx Judgment Overturned On Appeal • Merck Agrees to Pay $58 Million to Settle Vioxx Claims • Researchers Claim Merck Cooked Vioxx Data • Common Pain Relievers May Boost Muscle Mass • More Painkillers Can Cause More Pain • Merck Caves, Agrees To $4.85 Billion Vioxx Settlement • New York Sues Vioxx Maker over Drug’s Risks • Merck Wins Vioxx Case In Illinois • Judge Rules Out Vioxx "Super" Class Action • FDA Critic Blasts Merck's Vioxx Replacement • Merck Loses New Orleans Vioxx Case • Merck Wins Latest Vioxx Suit • Vioxx Study Authors Backtrack On Claim • Older Painkillers May Increase Heart Attack Risk • More about Vioxx --- Other NSAIDs • Bextra • Celebrex • Dangers of Other Vioxx-Type Drugs • Vioxx Alternatives • Aleve Ingredient Seen as Health Risk

An Atlantic City, New Jersey jury has sided with pharmaceutical giant Merck & Co., agreeing that the company fulfilled its requirements under the law when it warned consumers about the risks of taking its pain medication Vioxx. The company had been sued for liability in the 2001 fatal heart attack of a man who had taken the drug.

The jury debated less than eight hours before delivering the verdict, exonerating Merck of the charges. It follows a trial this past summer in Texas, where the drugmaker was found liable in the death of a Vioxx user.

In the New Jersey trial, Merck kept the focus on medical evidence. It called witnesses who testified the company believed Vioxx was safe before it abruptly pulled it from the market in September 2004.

The six-woman, three-man jury reached the conclusion that the company’s disclosure about possible risks from Vioxx met its obligations, and that it could not be held responsible for the death of 60 year old Mike Humeston, who was taking Vioxx for pain from a Vietnam War injury.

The jury also ruled that Merck properly warned doctors about risks with Vioxx and voted unanimously on three counts that Merck did not mislead doctors about the drug's safety.

The stakes couldn't have been higher in the New Jersey case. More than half the 5,000 personal injury suits against Merck have been filed in New Jersey, where Superior Court Judge Carol Higbee certified a national class action covering every private third-party payer that allowed members of its health benefits plan to buy Vioxx.

Despite the latest victory, Merck lawyers will stay busy over the next few years. The pharmaceutical company faces at least 6,000 similar lawsuits.

Report Your Experience
If you've had a bad experience -- or a good one -- with a consumer product or service, we'd like to hear about it. All complaints are reviewed by class action attorneys and are considered for publication on our site. Knowledge is power! Help spread the word. File your consumer report now.

Share		Follow us on Twitter.